Chesapeake Energy (NASDAQ:CHK) reported quarterly earnings of $4.87 per share which beat the analyst consensus estimate of $3.81 by 27.82 percent. This is a 196.95 percent increase over earnings of $1.64 per share from the same period last year.
HC Wainwright & Co. Maintains Buy on Century Therapeutics, Lowers Price Target to $19
HC Wainwright & Co. analyst Mitchell Kapoor maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target from $25 to $19.
